Abstract:Summary Background Influenza A (H3N2) virus (A/H3N2) has complex antigenic evolution, resulting in frequent vaccine strain updates. We aimed to evaluate the protective effect of the vaccine strains on the circulating strains from past ten years and provide a basis for finding a broader and more efficient A/H3N2 vaccine strain. Methods Eighty-four representative circulating A/H3N2 strains were selected from 65,791 deposited sequences in 2011–2020 and pseudotyped viruses were constructed with the VSV vector. We immunized guinea pigs with DNA vaccine containing the A/H3N2 components of the vaccine strains from 2011 to 2021 and tested neutralizing antibody against the pseudotyped viruses. We used a hierarchical clustering method to classify the eighty-four representative strains into different antigenic clusters. We also immunized animals with monovalent vaccine stock of the vaccine strains for the 2020–2021 and 2021–2022 seasons and tested neutralizing antibody against the pseudotyped viruses. Findings The vaccine strains PE/09, VI/11 and TE/12 induced higher levels of neutralizing antibody against representative strains circulating in recommended year and the year immediately prior whereas vaccine strains HK/14, HK/19 and CA/20 induced poor neutralization against all representative strains. The representative strains were divided into five antigenic clusters (AgV), which were not identical to gene clades. The AgV5 strains were most difficult to be protected among the five clusters. Compared with single-dose immunization, three doses of monovalent vaccine stock (HK/19 or CA/20) could induce stronger and broader neutralizing antibodies against strains in each of the antigenic clusters. Interpretation The protective effect of vaccine strains indicated that the accurate selection of A/H3N2 vaccine strains must remain a top priority. By increasing the frequency of immunization, stronger and broader neutralizing antibodies against strains in all antigenic clusters were induced, which provides direction for a new immunization strategy. Funding This work was supported by a grant from National Key R&D Program of China (No. 2021YFC2301700).

Early Recognition of Emerging Flu Strain Clusters

Computer-assisted vaccine design

Modeling the Antigenic Evolution of Seasonal Influenza Viruses with PREDAC for Vaccine Strain Selection in the Season of 2025

Timely vaccine strain selection and genomic surveillance improves evolutionary forecast accuracy of seasonal influenza A/H3N2

A Novel Sequence-Based Antigenic Distance Measure for H1N1, with Application to Vaccine Effectiveness and the Selection of Vaccine Strains

Low-dimensional clustering detects incipient dominant influenza strain clusters

Using A Mutual Information-Based Site Transition Network to Map the Genetic Evolution of Influenza A/H3n2 Virus

Influenza Virus Vaccine Efficacy Based On Conserved Sequence Alignment

Leveraging Pre-Vaccination Antibody Titers across Multiple Influenza H3N2 Variants to Forecast the Post-Vaccination Response

Mapping of H3N2 Influenza Antigenic Evolution in China Reveals a Strategy for Vaccine Strain Recommendation

A sequence-based machine learning model for predicting antigenic distance for H3N2 influenza virus

A general solution to broad-spectrum vaccine design for rapidly mutating viruses

Models for predicting the evolution of influenza to inform vaccine strain selection

Retrospective immunogenicity analysis of seasonal flu H3N2 vaccines recommended in the past ten years using immunized animal sera

Predicting the Mutating Distribution at Antigenic Sites of the Influenza Virus.

The Potential Benefits of Delaying Seasonal Influenza Vaccine Selections for the Northern Hemisphere: A Retrospective Modeling Study in the United States

Predicting Influenza H3N2 Vaccine Efficacy From Evolution of the Dominant Epitope

Predictive evolutionary modelling for influenza virus by site-based dynamics of mutations

Prediction of Influenza B Vaccine Effectiveness from Sequence Data

Time series computational prediction of vaccines for influenza A H3N2 with recurrent neural networks

Integrating influenza antigenic dynamics with molecular evolution